Skip to main content

Multi drug resistant tuberculosis

This is a preview of subscription content, access via your institution.

References

  1. Isemann MD. Treatment of multidrug resistant tuberculosis.N Engl J Med 1993; 329:784–791.

    Article  Google Scholar 

  2. Dooley SW, Jarvis WR, Martone WJet al. Multidrug resistant tuberculosis.Ann Intern Med 1992;117:257–258.

    PubMed  CAS  Google Scholar 

  3. Raviglione MC, Snider Snider DE, Kochi A. Global epidemiology of tuberculosis Morbidity and Mortality of a world wide epidemic.JAMA 1995;273:220–226.

    PubMed  Article  CAS  Google Scholar 

  4. Vareldzis BP, Grosset J, Kantor IDet al. Laboratory evaluation of drug resistant tuberculosis. Document WHO/TB. 1993; 171:3–16.

    Google Scholar 

  5. Heym B, Cole ST. Isolation and characterization of isoniazid-resistant mutants of M. Smegmatis.Res Microbiol 143:721–730.

  6. Cole ST. Mechanisms of drug resistance in Mycobacterium tuberculosis.Immunobiol 1994;191:584–585.

    CAS  Google Scholar 

  7. Winder FG, Collins PB. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis.J Gen Microbiol 1970;63:41–48.

    PubMed  CAS  Google Scholar 

  8. Freiden TR, Sterling T, Pablos M. The emergence of drug resistant tuberculosis in New York City.N Engl J Med 1993;328:521–526.

    Article  Google Scholar 

  9. Goble M, Iseman MD, Madsen LAet al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin.N Engl J Med 1993;328:527–532.

    PubMed  Article  CAS  Google Scholar 

  10. Snider DE, Cauthen GM, Farer LSet al. Drug resistant tuberculosis.Am Rev Respir Dis 1991;144:732–736.

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chopra, K. Multi drug resistant tuberculosis. Indian J Pediatr 63, 159–162 (1996). https://doi.org/10.1007/BF02845239

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02845239

Keywords

  • Tuberculosis
  • Drug Resistance
  • Rifampicin
  • Isoniazid
  • Multi Drug Resistant